Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Geyer

Showing results (41-50 of 256) with videos related to

Pageof 26
Sort By:
The New England Journal of Medicine|October 6, 2021
Adjuvant Olaparib in BRCA-Mutated Breast Cancer. ReplyAndrew N J Tutt, Judy E Garber, Charles E Geyer
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Drug development: neoadjuvant opportunities in breast cancerPriya Rastogi, Charles E Geyer, Eleftherios P Mamounas, et al.
Molecular Systems Biology|September 28, 2017
Revisiting biomarker discovery by plasma proteomicsPhilipp E Geyer, Lesca M Holdt, Daniel Teupser, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1995
Intraoperative radiation therapy in advanced thyroid cancerG Wolf, E Geyer, W Langsteger, et al.
Cancer Research|November 1, 1980
Quantitative estimation of cellular retinoic acid-binding protein activity in normal, dysplastic, and neoplastic human breast tissueW M Küng, E Geyer, U Eppenberger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2010
Efficacy and cardiac safety of adjuvant trastuzumab-based chemotherapy regimens for HER2-positive early breast cancerR B Costa, G Kurra, L Greenberg, et al.
Molecular & Cellular Proteomics : MCP|January 14, 2021
Plasma Proteomes Can Be Reidentifiable and Potentially Contain Personally Sensitive and Incidental FindingsPhilipp E Geyer, Sebastian Porsdam Mann, Peter V Treit, et al.
Epilepsy & Behavior : E&B|January 23, 2017
Epilepsy and restless legs syndromeJames D Geyer, Emery E Geyer, Zachary Fetterman, et al.
Parasitology|March 1, 1996
Neutral glycolipids of Schistosoma mansoni as feasible antigens in the detection of schistosomiasisR D Dennis, S Baumeister, G Lauer, et al.
Molecular and Biochemical Parasitology|July 1, 1992
Comparative serological reactivity of Taenia crassiceps, Taenia solium and Taenia saginata metacestode neutral glycolipids to infection serum from Taenia crassiceps-infected miceS Baumeister, R D Dennis, J Kunz, et al.
Pageof 26

Showing results (41-50 of 256) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|October 6, 2021
Adjuvant Olaparib in BRCA-Mutated Breast Cancer. ReplyAndrew N J Tutt, Judy E Garber, Charles E Geyer
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Drug development: neoadjuvant opportunities in breast cancerPriya Rastogi, Charles E Geyer, Eleftherios P Mamounas, et al.
Molecular Systems Biology|September 28, 2017
Revisiting biomarker discovery by plasma proteomicsPhilipp E Geyer, Lesca M Holdt, Daniel Teupser, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1995
Intraoperative radiation therapy in advanced thyroid cancerG Wolf, E Geyer, W Langsteger, et al.
Cancer Research|November 1, 1980
Quantitative estimation of cellular retinoic acid-binding protein activity in normal, dysplastic, and neoplastic human breast tissueW M Küng, E Geyer, U Eppenberger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2010
Efficacy and cardiac safety of adjuvant trastuzumab-based chemotherapy regimens for HER2-positive early breast cancerR B Costa, G Kurra, L Greenberg, et al.
Molecular & Cellular Proteomics : MCP|January 14, 2021
Plasma Proteomes Can Be Reidentifiable and Potentially Contain Personally Sensitive and Incidental FindingsPhilipp E Geyer, Sebastian Porsdam Mann, Peter V Treit, et al.
Epilepsy & Behavior : E&B|January 23, 2017
Epilepsy and restless legs syndromeJames D Geyer, Emery E Geyer, Zachary Fetterman, et al.
Parasitology|March 1, 1996
Neutral glycolipids of Schistosoma mansoni as feasible antigens in the detection of schistosomiasisR D Dennis, S Baumeister, G Lauer, et al.
Molecular and Biochemical Parasitology|July 1, 1992
Comparative serological reactivity of Taenia crassiceps, Taenia solium and Taenia saginata metacestode neutral glycolipids to infection serum from Taenia crassiceps-infected miceS Baumeister, R D Dennis, J Kunz, et al.
Pageof 26